Stigmabase | HIV

Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

Posts

Showing posts matching the search for Long-Acting Injectable HIV Therapy: Addressing Adherence Challenges

Show all

Long-Acting Injectable HIV Therapy: Addressing Adherence Challenges

South Africa Time — Wednesday, October 23, 2024

Long-acting injectable antiretroviral therapy using cabotegravir and rilpivirine (LAI CAB/RPV) has shown superior outcomes compared to daily oral ... View article...

Racial Xperience

JOHANNESBURG

Stigmabase is a canadian non-profit internet initiative dedicated to informing and raising awareness on the damaging effects of social exclusion and stigma around the world. The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

2010 - 2026 ― Stigmabase Global Initiative || Keeping up-to-date on global exclusion

ABOUT STIGMABASE
Request for Review